Artificially cloaked viral nanovaccine for cancer immunotherapy
Cancer therapy using oncolytic virus has shown pre-clinical and clinical efficacy. Here, the authors report ExtraCRAd, an oncolytic virus cloaked with tumour cell membrane and report its therapeutic effects in vitro and in vivo in multiple mouse tumour models.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2b72055f0b5e4f6496735a1c2b068f78 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|